A UK consensus algorithm for early treatment modification in newly diagnosed systemic light‐chain amyloidosis

Summary Depth of response is the critical determinant of prognosis in amyloid light‐chain (AL) amyloidosis. Here, we aim to identify patients who are unlikely to improve response based on analysis of baseline characteristics and 1‐month response. In a multivariate model, difference in involved amylo...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:British journal of haematology Ročník 198; číslo 2; s. 328 - 332
Hlavní autoři: Ravichandran, Sriram, Mahmood, Shameem, Wisniowski, Brenden, Sachchithanantham, Sajitha, Popat, Rakesh, Lachmann, Helen, Rabin, Neil, Ramasamy, Karthik, Hawkins, Stephen, Kyriakou, Charalampia, Gillmore, Julian, Yong, Kwee, Hawkins, Philip, Jackson, Graham, Pratt, Guy, D. Wechalekar, Ashutosh
Médium: Journal Article
Jazyk:angličtina
Vydáno: England Blackwell Publishing Ltd 01.07.2022
Témata:
Amyloid
Amyloidogenesis
Amyloidosis
Hematology
Light chains
MGUS
multiple myeloma
Patients
MGUS
multiple myeloma
amyloidosis
ISSN:0007-1048, 1365-2141, 1365-2141
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Popis
Shrnutí:Summary Depth of response is the critical determinant of prognosis in amyloid light‐chain (AL) amyloidosis. Here, we aim to identify patients who are unlikely to improve response based on analysis of baseline characteristics and 1‐month response. In a multivariate model, difference in involved amyloidogenic and uninvolved serum free light chains (dFLC) at diagnosis (dFLC >400 mg/l, odds ratio [OR] 4.051, p < 0.005) and no response at 1 month (OR 4.787, p < 0.005) were significant predictors of no improvement in response. Only 5% of patients with a dFLC of >400 mg/l and no response at 1 month improved their response (p < 0.005). We suggest that these patients should switch treatment early, subject to their functional status.
Bibliografie:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0007-1048
1365-2141
1365-2141
DOI:10.1111/bjh.18216